Evidence map›Paper›PMID 29887788›Full record

ArticleBreast care (Basel, Switzerland)2018

Using a New Marker Clip System in Breast Cancer: Tumark Vision® Clip - Feasibility Testing in Everyday Clinical Practice.

Anna Marlene Rüland, Friederike Hagemann, Mattea Reinisch, Johannes Holtschmidt, Aylin Kümmel, Christine Dittmer-Grabowski, Frank Stöblen, Horst Rotthaus, Volker Dreesmann, Jens-Uwe Blohmer and 1 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Breast care (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04468113 (Prospective, Multicenter Registry Study Evaluating the Feasibility of Ultrasound-guided Clipping of Suspicious Intramammary Lesions in Primary Breast Cancer Patients Receiving Neoadjuvant Therapy), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04468113 completednot on this mapstarted 2020, after this paper: background citation

Prospective, Multicenter Registry Study Evaluating the Feasibility of Ultrasound-guided Clipping of Suspicious Intramammary Lesions in Primary Breast Cancer Patients Receiving Neoadjuvant Therapy (Ultra3Detect)

TypeobservationalSponsorKliniken Essen-MitteRan2020 to 2023Enrolled339ConditionsPrimary Breast CancerArmsTumark® Vision clip
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Anna Marlene RülandSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Friederike HagemannSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Mattea ReinischSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Johannes HoltschmidtSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Aylin KümmelSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Christine Dittmer-GrabowskiSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Frank StöblenSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Horst RotthausSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Volker DreesmannSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Jens-Uwe BlohmerDepartment of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Campus Mitte and Benjamin Franklin, Berlin, Germany.
Sherko KümmelSenology/Breast Care Unit, Evangelische Huyssens-Stiftung, Kliniken Essen Mitte, Essen, Germany.
Kliniken Essen-Mitte · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study presents first feasibility experiences with a new 3-dimensional (3D) marker clip system in clinical practice. The rate of clinical complete responses in the treatment of breast cancer patients is increasing; additionally, a change to targeted axillary dissection is being considered after neoadjuvant chemotherapy (NACT). Consequently, marker clips are needed which are reliable and easy to handle even in the axillary lymph node system.

methodsA total of 50 patients from the Breast Care Unit of the Kliniken Essen Mitte were included. Clip marking of all 50 primary breast cancer lesions as well as 23 lymph nodes was performed using the Tumark Vision® clip. Following application, the position and visibility of the marker clip were monitored and documented in 2 axes.

resultsThe feasibility of the Tumark Vision clip was excellent in everyday clinical practice as none of the markers dislocated. After clip marking of the tumor region and/or suspicious lymph nodes, all Tumark Vision clips could be detected in both axes. The 3D shape could be observed in all cases after application.

conclusionThe new 3D-shaped marker clip seems to be a promising tool for marking breast cancer lesions and even lymph nodes before NACT. As there are many studies ongoing to prove the feasibility of a shift from standard axillary dissection after NACT towards targeted axillary dissection, the Tumark Vision clip seems to provide good visibility even in lymph nodes after NACT. Further studies are warranted.

Indexed as

Breast cancerClipTargeted axillary dissectionUltrasound

Identifiers

PMID29887788
PMCPMC5981593
OpenAlexW2793656180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.